Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System

NACompletedINTERVENTIONAL
Enrollment

362

Participants

Timeline

Start Date

April 18, 2022

Primary Completion Date

December 11, 2023

Study Completion Date

December 11, 2023

Conditions
Atrial Fibrillation
Interventions
DEVICE

Pulse Field Ablation

PFA ablation using a circular multi-electrode pulsed electrical field catheter and multichannel generator

Trial Locations (30)

10016

New York University Langone Med Center, New York

10021

New York Presbyterian Hospital, New York

10029

Mount Sinai School of Medicine, New York

10561

Albert Einstein College of Medicine, The Bronx

11706

South Shore University Hospital, Bay Shore

19104

Penn Presbyterian Medical Center, Philadelphia

20010

Medstar Washington Hospital Center, Washington D.C.

21231

Johns Hopkins, Baltimore

22042

Inova Fairfax Medical Center, Falls Church

23285

Virginia Commonwealth Uninversity, Richmond

27157

Wake Forest Baptist Health, Winston-Salem

27610

Wakemed Heart and Vascular, Raleigh

30309

Piedmont Healthcare, Atlanta

30342

Emory Saint Joseph's Hospital, Atlanta

31404

Memorial Health University Medical Center, Savannah

32803

Florida Hospital, Orlando

35243

Grandview Medical Center, Birmingham

44195

Cleveland Clinic Foundation, Cleveland

55414

Minneapolis Heart Institute, Minneapolis

60201

Evanston Hospital / Northshore, Evanston

72401

Arrhythmia Research Group (St. Bernards), Jonesboro

75093

Baylor Research Institute, Plano

78705

Texas Cardiac Arrhythmia Research Foundation, Austin

85016

Phoenix Cardiovascular Research, Phoenix

92123

San Diego Cardiac Center, San Diego

92663

Hoag Memorial Hospital, Newport Beach

94904

Cardiovascular Group of Marin/SF Med Group, Larkspur

02114

Massachusetts General Hospital, Boston

02115

Brigham and Women's Hospital, Boston

07960

Morristown Medical Center, Morristown

All Listed Sponsors
lead

Biosense Webster, Inc.

INDUSTRY